I'm interested in developing new drug in veterinary medicine by changing the molecular aspect or find a new alternative treatment to some advance disease that's been happening in the world right now. (Sorry for the poor english)
Generally product development raises the need for DEI: https://www.researchgate.net/publication/380427514_Kalergi_and_Hart-Cellerand_Memetics_White_Antifragility
Evaluation of the efficacy of Devil’s claw (Harpagophytum procumbens/zeyheri)) by - products on arthritis in animals and humans Globally and Develop a Unique Product.
Saint Roch Veterinary, LLC will market a new product based on a patented molecule that halts canine periodontitis by treating biofilms. Not long ago, periodontitis was said to be "incurable," but an AI search now states otherwise, but in guarded terms. A true cure would not only halt the disease, but perhaps with higher stated goals actually promote new bone and ligament growth. That is said to be possible using such as STEM cells and grafts. However, the new product will break down biofilms and convert the pathologic biofilm in the subgingival sulcus to a biofilm compatible with the canine's commensal biofillm. The beneficial effect persists with a single topical treatment for many weeks, up to 6+ months with breed variance; this allows for at home treatments to extend the time benefit of scaling and polishing under general anesthesia. A very new product based on a safety study and a 100 plus dog clinical study, likely to reach the market in a few months.
Newest development in veterinary pharmaceutical is this new novel oral acaricided Flurainer trade name Bravecto for prevention and extermination of Tick and fleas